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ABSTRACT Fos and Jun form dimeric complexes that
bind to activator protein 1 (AP-1) DNA sequences and regulate
gene expression. The levels of expression and activities of these
proteins are regulated by a variety of extracellular stimuli.
They are thought to function in nuclear signal transduction
processes in many different cell types. The role of Fos and Jun
in gene transcription is complex and may be regulated in
several ways including association with different dimerization
partners, interactions with other transcription factors, effects
on DNA topology, and reduction/oxidation of a conserved
cysteine residue in the DNA-binding domain. In addition,
phosphorylation has been suggested to control the activity of
Fos and Jun. Here we show that phosphorylation of Fos and
Jun by several protein kinases is affected by dimerization and
binding to DNA. Jun homodimers are phosphorylated effil-
ciently by casein kinase II, whereas Fos-Jun heterodimers are
not. DNA binding also reduces phosphorylation of Jun by
casein kinase II, p34¢dc2 (cdc2) kinase, and protein kinase C.
Phosphorylation ofFos by cAMP-dependent protein kinase and
cdc2 is relatively insensitive to dimerization and DNA binding,
whereas phosphorylation of Fos and Jun by DNA-dependent
protein kinase is dramatically stimulated by binding to the
AP-1 site. These results imply that different protein kinases can
distinguish among Fos and Jun proteins in the form of mono-
mers, homodimers, and heterodimers and between DNA-
bound and non-DNA-bound proteins. Thus, potentially, these
different states of Fos and Jun can be recognized and regulated
independently by phosphorylation.
The regulation of eukaryotic gene transcription requires the
concerted action of many proteins that bind directly or
indirectly to DNA regulatory elements. The molecular mech-
anisms that dictate the ordered assembly of these complexes
are currently not well understood. This issue is particularly
relevant for transcription factors that are encoded by gene
families because these proteins may have similar structures
and DNA-binding specificities, but distinct functions. The
mammalian transcription factor AP-1 corresponds to a DNA-
binding activity that is made up of multiple proteins including
all of the members of thefos andjun gene families (1). These
proteins bind to DNA as dimers formed by interaction of
leucine zipper domains (2-6). Dimerization brings into close
proximity a region of each subunit rich in basic amino acids
that provides a bimolecular DNA contact surface (7-9). The
three Jun family members bind toDNA either as homodimers
or as heterodimers formed among themselves or with mem-
bers of the Fos and activating transcription factor/cAMP
responsive element binding protein (ATF/CREB) families
(10-12). The four Fos family members bind to DNA as
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heterodimers with the Jun family and with selected members
of the ATF/CREB family, but they do not form stable
homodimers (12, 13). At present, more than 50 different
complexes can be formed among the known subunits, and
many of these complexes have been shown to exist in vivo
(14).
In most cell types, members ofthefos andjun gene families
are expressed at relatively low levels, but they are induced
transiently by a wide range of extracellular stimuli (15). They
are thought to function as cellular immediate-early genes in
coupling extracellular signals to phenotypic responses by
regulating the expression of specific target genes. Although
these genes exhibit cell type, stimulus, and temporal speci-
ficity of expression, a relatively large subset can be coex-
pressed in any given situation. Therefore, mechanisms must
exist that permit the recognition and assembly of specific
dimeric complexes with the appropriate DNA regulatory
element.
Several potential mechanisms have been identified that are
likely to contribute to the specificity of AP-1 proteins. The
many protein dimers exhibit distinct specificities and affini-
ties forDNA sequences containing different AP-1 and cAMP
responsive element binding sites (12, 16). Fos and Jun family
proteins display different transcriptional properties in
cotransfection (17, 18) and in vitro transcription (19) assays.
DNA-binding activity is modulated by an unusual oxidation/
reduction mechanism that involves a conserved cysteine
residue located in the DNA-binding domain (20-22). Fur-
thermore, Fos and Jun induce DNA bends of opposite
orientation, suggesting that DNA topology may play a role in
the assembly of higher order transcriptional complexes in-
volving AP-1 proteins (9, 23). In addition to all of these
properties, posttranslational modification by phosphoryla-
tion may have a significant effect. Both Fos and Jun are
highly phosphorylated on serine and threonine residues.
Multiple protein kinases including glycogen synthase kinase
III, mitogen-activated protein kinase, casein kinase II
(CKII), p34cdc2 kinase (cdc2), cAMP-dependent protein ki-
nase (PKA), and protein kinase C (PKC) have been reported
to phosphorylate either Fos or Jun on several sites in vitro.
However, the relationship between phosphorylation and
function is complex. Phosphorylation of Jun often has been
reported to be increased (24-27) or decreased (28, 29) after
treatment of cells with extracellular stimuli. Furthermore, it
has been suggested that phosphorylation of Fos increases its
ability to inhibit serum response element-mediated transcrip-
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tion (30). Cotransfection studies have suggested that phos-
phorylation of the C terminus ofJun decreased DNA-binding
activity (28, 29), whereas phosphorylation of serine residues
in the N terminus of Jun increased transcriptional activation
(29). In contrast, we showed that phosphorylation of Jun in
vitro had only modest effects on DNA binding and transcrip-
tional activation (26). These discrepancies between cotrans-
fection and in vitro studies imply that the effect of phosphor-
ylation on Jun activity may only be understood in the context
of higher order interactions that occur within cells. Thus,
there is no simple relationship between phosphorylation and
the function of Fos and Jun.
Here we have investigated the ability of Fos and Jun to be
phosphorylated as monomers (in the case of Fos), ho-
modimers (in the case of Jun), and heterodimers, in the
presence and absence of the AP-1 binding site. The results
show that dimerization and DNA binding have a dramatic
effect on the ability of several protein kinases to phosphor-
ylate Fos and Jun. However, the effect observed was depen-
dent upon the specific protein kinase used. Thus, phosphor-
ylation may serve a role in discriminating among the multiple
states of Fos and Jun that exist within cells and may con-
tribute to the specificity of assembly of higher order com-
plexes.
MATERIALS AND METHODS
Proteins and Kinases. The sequences corresponding to the
entire coding region of c-fos (rat) and c-jun (rat) were
expressed in Escherichia coli as hexahistidine fusion proteins
and purified by nickel affinity chromatography as described
(7). PKA (catalytic subunit) was purchased from Sigma.
Mitotically active p34cdc2 (cdc2) was purified as described
from nocodazole-treated HeLa cells. This preparation exhib-
ited no detectable contamination with seven other classes of
protein kinases (31). Purified PKC produced from baculo-
virus vector-infected insect cells was a generous gift of Sue
Jaken (W. Alton Jones Cell Science Center, Lake Placid,
NY). CKII was purified as described (32). DNA-dependent
protein kinase (DNA-PK) was purified from HeLa cells as in
ref. 33. pp44mapk was isolated from 208F rat fibroblasts after
serum stimulation by using polyclonal antiserum obtained
from John Blenis (Harvard Medical School, Boston).
pp44mapk immunoprecipitation and kinase assays were per-
formed as described (34). Oligonucleotides containing the
SP-1 or AP-1 binding sites were as described (35).
Kinase Reactions. Phosphorylation reactions were per-
formed at 30°C for 30-45 min in the appropriate reaction
mixtures as described (25, 26, 34, 36). DNA-PK reactions in
the presence ofDNA included calf thymus DNA at 10 ,ug/ml.
Each assay contained Fos or Jun at a concentration of 0.5
,uM. All assays also included 1-5 mM dithiothreitol to main-
tain the proper redox conditions required forDNA binding by
Fos and Jun (21). In assays that included AP-1 or SP-1
oligonucleotides, a concentration of 0.5 uM oligonucleotide
was used. This represents a 2-fold molar excess relative to
protein-dimer concentration in the reaction. For quantitation
purposes, two different concentrations of protein dimers
were analyzed in the absence and presence of DNA. In the
first instance, the molar concentration of Fos and Jun was
identical to that used when the proteins were assayed alone,
as shown in the figures. In the second instance, the overall
protein concentration was identical to that used when the
proteins were assayed alone. Thus, in the latter case there
was a 50% reduction in the molar concentration of Fos and
Jun. Laser densitometric scanning was used to quantitate
differences in phosphorylation. Tryptic phosphopeptide
mapping was performed in situ on nitrocellulose filters (37).
Briefly, Fos and Jun proteins in the form of monomers,
homodimers, and heterodimers, bound to an AP-1 oligonu-
cleotide or in the absence of a DNA binding site, were
phosphorylated using [y.32P]ATP, separated by SDS/PAGE,
and transferred electrophoretically to nitrocellulose filters.
The labeled proteins were excised, digested with trypsin,
subjected to performic acid oxidation, and separated on
high-resolution Tris/N-tris(hydroxymethyl)methylglycine/
urea gels as described (26). The radiolabeled phosphopep-
tides were visualized by autoradiography.
RESULTS AND DISCUSSION
Full-length Fos and Jun proteins were expressed in E. coli as
hexahistidine fusion proteins and were purified to apparent
homogeneity as described (19) for use as substrates in phos-
phorylation assays. These proteins form dimers and bind to
DNA with high efficiency, and they are capable of activating
transcription from AP-1 sites in vitro. As demonstrated
previously, Fos and Jun are excellent substrates for several
different protein kinases in vitro (25, 26). In the case of Fos,
efficient phosphorylation was observed with cdc2, PKC,
PKA, and pp44mapk (Fig. 1) but not with CKII (Fig. 2). In the
case of Jun, phosphorylation by PKA was inefficient (Fig.
1C), whereas PKC, cdc2, and CKII all phosphorylated Jun
efficiently. pp44mapk phosphorylated Jun, although to a much
lesser extent than phosphorylation of Fos (Fig. 1D). Under
the conditions used in these experiments, Fos exists in
solution primarily as a monomer and Jun as a homodimeric
complex when assayed independently. When mixed together
in solution, virtually all of the Fos and Jun combine to form
heterodimers (38).
Dimerization and DNA Binding Reduce Phosphorylation of
Fos and Jun by Selected Protein Kinases. To assess the
influence of dimerization and DNA binding on phosphory-
lation of Fos and Jun, equimolar mixtures of each protein
were preincubated in the presence and absence of an oligo-
nucleotide containing an AP-1 binding site prior to phosphor-
ylation. Phosphorylation of Fos and Jun by cdc2 was only
modestly reduced by <2-fold following dimerization (Fig.
1A). Similarly, addition of an AP-1 oligonucleotide had little
effect (less than a 2-fold reduction) on phosphorylation ofFos
monomers (compare lanes 1 and 4). In contrast, DNA binding
significantly reduced phosphorylation of Jun homodimers by
-5-fold (compare lanes 2 and 5). These effects were less
pronounced on Jun in the context ofa heterodimeric complex
(compare lanes 3 and 6). Phosphorylation of Fos and Jun by
PKC was not affected by dimerization in the absence ofDNA
(Fig. 1B). Although the presence of DNA only modestly
reduced phosphorylation ofFos monomers (1.2-fold) and Jun
homodimers (2.5-fold) by PKC, phosphorylation of Jun, but
not Fos, in a heterodimeric complex was reduced by 10-fold
(Fig. 1B, lane 6). Therefore, a significant reduction in Jun
phosphorylation resulted from a combination of dimerization
and DNA binding.
Phosphorylation of Fos and Jun by some kinases was not
affected by either dimerization or DNA binding. For exam-
ple, phosphorylation of Fos and Jun by PKA and p44mapk was
essentially unaffected by dimerization and DNA binding (Fig.
1 CandD).
CKII exhibited a surprisingly high degree of specificity for
Jun homodimers in the absence ofDNA (Fig. 2). Phosphor-
ylation of Jun by CKII was severely reduced both by dimer-
ization with Fos and by binding to the AP-1 site (>10-fold).
The effect of DNA was specific to the AP-1 site because an
oligonucleotide containing an SP-1 binding site had no effect
on phosphorylation of Jun by CKII (lane 8). Similarly, all of
the kinases evaluated were tested with Fos monomers, Jun
homodimers, or Fos-Jun heterodimers in the presence of an
oligonucleotide containing the SP-1 binding site. In all cases,
the SP-1 oligonucleotide had no effect on the levels of
phosphorylation when compared to reactions performed in
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FIG. 2. Dimerization and DNA binding inhibit Jun phosphory-
lation by CKII. Fos and Jun proteins, at a concentration of 0.5 AM
each, were tested as substrates for CKII in the form of Fos (F)
monomers (lanes 1, 4, and 7), Jun (J) homodimers (lanes 2, 5, and 8),
or Fos-Jun (F + J) heterodimers (lanes 3, 6, and 9). Phosphorylation
reactions were performed in the absence ofDNA (lanes 1-3), in the
presence of an oligonucleotide (oligo) containing the AP-1 site (lanes
4-6), or in the presence ofan oligonucleotide containing the SP-1 site
(lanes 7-9). Labeled proteins were separated and visualized as in Fig.
1.
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FIG. 1. Effect of dimerization and DNA binding on phosphory-
lation efficiency is kinase specific. Fos and Jun proteins at a
concentration of 0.5 ,uM each were tested as substrates in the form
of Fos (F) monomers (lanes 1 and 4) and Jun (J) homodimers (lanes
2 and 5) or as Fos-Jun (F + J) heterodimers (lanes 3 and 6) in the
presence (lanes 4-6) or absence (lanes 1-3) ofa 0.5 ,M concentration
of an oligonucleotide (oligo) containing the AP-1 binding site. Pro-
teins were labeled with [y-32P]ATP by the indicated kinase, separated
on an SDS/9%o polyacrylamide gel, and visualized by autoradiogra-
phy. (A) p34cdc2 kinase. (B) PKC. (C) PKA. (D) pp44mapk.
the absence of DNA (data not shown and Fig. 2). Further-
more, the effects of the AP-1 oligonucleotide appear to be
substrate specific as phosphorylation of histone Hi protein
by cdc2 was not altered by the presence of AP-1 or SP-1
oligonucleotides (data not shown). Taken together, these
results indicate that dimerization and DNA binding alter the
substrate specificity of different protein kinases for Fos and
Jun.
DNA Binding Enhances Phosphorylation of Fos and Jun by
DNA-PK. One concern about the above results is that DNA
binding could simply reduce phosphorylation of Fos and Jun
nonspecifically because of steric hindrance. Therefore, we
examined the phosphorylation of Fos and Jun by a protein
kinase that is activated in the presence of DNA, DNA-PK
(33). DNA-PK phosphorylates simian virus 40 large tumor
antigen, SP-1, and several other DNA-binding proteins (33,
39). Recently, DNA-PK has been demonstrated to consist of
a complex that includes the human autoimmune antigen Ku,
corresponding to a 70-kDa and an 80-kDa subunit. The active
kinase represents a complex ofKu proteins bound to double-
stranded DNA ends in association with the 350-kDa protein
kinase catalytic subunit (40, 41). DNA-PK is activated in the
presence of nonspecific DNA (usually calf thymus oligonu-
cleotides). Therefore, we assayed the ability of DNA-PK to
phosphorylate Fos and Jun in the presence and absence of
calf thymus oligonucleotides (Fig. 3). Very low levels of
phosphorylation were observed in the absence of DNA, and
a significant increase in phosphorylation of Fos and Jun was
observed in the presence of calf thymus DNA.
Dimerization did not significantly reduce phosphorylation
of Fos and Jun by DNA-PK. A dramatic stimulation of
phosphorylation was obtained in the presence of an oligonu-
cleotide containing an AP-1 binding site (>30-fold). DNA
binding enhanced phosphorylation of Fos monomers, Jun
homodimers, and Fos-Jun heterodimers. This effect was
specific to the AP-1 site as no enhanced phosphorylation was
observed in the presence of an oligonucleotide containing an
Sp-1 site (data not shown). The increased phosphorylation of
Fos monomers in the presence ofthe AP-1 site was somewhat
surprising and may reflect a low-affinity DNA-binding activ-
ity of Fos. Thus, DNA binding can result in either inhibition
or stimulation of phosphorylation depending on the protein
kinase used. The dramatic increase in phosphorylation ofFos
and Jun by DNA-PK in the presence of an AP-1 oligonucle-
otide is likely a consequence of the simultaneous occupation
ofa single DNA molecule by both enzyme and substrate (41).
Phosphopeptide Mapping Analysis. To determine whether
specific regions of Fos and Jun were particularly sensitive to
A
B
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FIG. 3. DNA binding enhances phosphorylation of Fos and Jun
by DNA-PK. Fos and Jun proteins, at a concentration of 0.5 PM,
were phosphorylated by DNA-PK in the form of Fos (F) monomers
(lanes 1, 4, and 7), Jun (J) homodimers (lanes 2, 5, and 8), or Fos-Jun
(F + J) heterodimers (lanes 3, 6, and 9). Reactions were performed
in the absence of DNA (lanes 1-3), in the presence of calf thymus
oligonucleotides at a concentration of 10 yg/ml (lanes 4-6), or in the
presence of calf thymus oligonucleotide plus an oligonucleotide
(oligo) containing the AP-1 site at a concentration of 0.5 ,uM (lanes
7-9). Labeled proteins were separated and visualized as in Fig. 1.
the effects of dimerization and DNA binding on phosphory-
lation, peptide mapping analysis was performed. In the case
of Fos, several peptides have been shown to be substrates for
a variety of protein kinases (24, 25). Although several phos-
phorylated regions of Fos have been identified, the exact
amino acids involved have not yet been identified. The
regions of Fos phosphorylated by cdc2 and DNA-PK were
unaffected by dimerization and DNA binding (Fig. 4A and
data not shown). Similarly, no specific effect was found using
PKC and PKA (data not shown). The major Fos peptide
phosphorylated by DNA-PK comigrated with the major
peptide phosphorylated by cdc2. This peptide lies in an
N-terminal domain of Fos, amino acids 58-139, that has been
associated with a reduction in transcriptional activity in vitro
(19). The same peptide is phosphorylated in serum-stimulated
fibroblasts.
In Fig. 4B, peptide maps of Jun phosphorylated in the
presence and absence ofDNA by cdc2, CKII, and DNA-PK
are presented. There was insufficient label in Jun phosphor-
ylated by CKII in the presence of Fos or DNA to prepare a
peptide map. DNA binding resulted in a reduction in all ofthe
cdc2 phosphorylation sites (Fig. 4B). Increased amounts of
the samples in lanes 2 and 4 were loaded on the gel to identify
phosphorylated peptides. Interestingly, in the presence ofthe
AP-1 site, phosphorylation of the same peptide was de-
creased using cdc2 and CKII and increased using DNA-PK.
This peptide lies in a region ofJun immediately N-terminal of
the DNA-binding domain. Thus, the effect of DNA binding
on phosphorylation is not a simple consequence of steric
hindrance. DNA-PK also phosphorylated one peptide that
was phosphorylated by CKII and an additional peptide of
unknown origin (Fig. 4B). The exact amino acids phosphor-
ylated in Jun by DNA-PK have not yet been determined.
CONCLUSIONS
Most in vitro studies of transcription factor phosphorylation
have utilized purified enzyme substrates incubated in the
absence ofDNA. While these have been useful in delineating
phosphorylation sites and potential kinases involved, it has
proven difficult to establish clear relationships between phos-
phorylation and function. One possible reason for this is that
the majority oftranscription factors function in the context of
protein complexes. Furthermore, in many situations tran-
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FIG. 4. Dimerization and DNA binding do not affect the sites of
phosphorylation. (A) Fos was phosphorylated with [t32P]ATP by
cdc2 or DNA-PK in the absence and presence of Jun and/or an
oligonucleotide (oligo) containing an AP-1 site as in Figs. 1 and 3. The
proteins were separated by SDS/PAGE and transferred onto nitro-
cellulose. Labeled Fos proteins were excised and digested with
trypsin, and peptides were resolved on tricine/urea gels (35). Lanes
1-3, 5, and 6, Fos monomers; lanes 4 and 7, Fos-Jun heterodimers.
Phosphorylation reactions in lanes 2 and 5-7 include an oligonucle-
otide containing an AP-1 site. Lanes 1, 3, and 4 do not include an
AP-1 oligonucleotide. All DNA-PK phosphorylations were per-
formed in the presence of calf thymus oligonucleotides at 10 4Lg/ml.
The arrowhead points to the major phosphopeptide. (B) Jun ho-
modimers were phosphorylated by cdc2 (lanes 1 and 2), CKII (lane
3), and DNA-PK (lanes 4 and 5) in the presence (lanes 2 and 5) or
absence (lanes 1, 3, and 4) of an oligonucleotide containing the AP-1
site as in Figs. 1-3. Peptide maps were generated as described in A.
Both DNA-PK reactions contained calf thymus DNA at 10 pLg/ml.
The arrowhead points to the major phosphopeptide.
scription factors that are involved in signal transduction
appear to be bound to DNA prior to stimulation (42). Fos and
Jun provide a unique opportunity to test the hypothesis that
protein complex formation and DNA binding affect the
specificity of phosphorylation. Both proteins are available in
pure form, and it is known that they can be phosphorylated
independently by a number of kinases. Here we show that
dimerization and DNA binding can have a profound influ-
ence, both negatively and positively, on the ability of these
proteins to be phosphorylated by several protein kinases.
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This does not appear to be a simple consequence of steric
hindrance because several regions of the proteins outside of
the dimerization and DNA-binding domains are affected.
Furthermore, DNA binding can either result in increased or
decreased phosphorylation of the same peptide in vitro.
Interestingly, a recent study demonstrated decreased phos-
phorylation of the C terminus of c-Jun in cells transfected
with a vector containing AP-1 binding sites when compared
to c-Jun from cells transfected with a control vector (43).
These observations imply that different states of Fos and Jun,
monomers, homodimers, heterodimers, DNA-bound, and
non-DNA-bound, can be recognized independently in the
cell.
It is remarkably difficult to determine which protein ki-
nases actually phosphorylate Fos and Jun under physiolog-
ical circumstances. Cotransfection studies can only indi-
rectly evaluate the effect of phosphorylation by removing a
target serine or threonine. Interpretation of these experi-
ments is further complicated by alteration in phosphorylation
of adjacent sites. For example, mutation of Ser-243 prevents
phosphorylation of Ser-249 by CKII (44) and results in
phosphorylation of a cryptic site at Thr-239 by cdc2 (26).
Furthermore, several kinases can apparently phosphorylate
the same peptides. In the case of Jun, the same peptide has
been phosphorylated by glycogen synthase kinase III (28),
cdc2, pp44mapk (26), DNA-PK (Fig. 4B), and CKII (26, 44). It
is likely that several of these kinases may be simultaneously
expressed within the cell. Changes in AP-1 activity may be
the contribution of only a small proportion of the total Fos
and Jun population present in the cell. However, analysis of
phosphorylated proteins isolated by immunoprecipitation
gives information about the average state of Jun phosphor-
ylation irrespective of whether it is bound to DNA, to Fos,
or to other proteins. Given the dramatic effect of Fos on Jun
phosphorylation by CKII, it is likely that other dimerization
partners can influence phosphorylation. Thus, it is not pos-
sible to make global statements about the role of phosphor-
ylation on Fos and Jun function. The exact kinase involved,
the dimeric state of the proteins, whether they are bound to
DNA and, indeed, their possible association with other
transcription factors must all be taken into account. This
level of complexity may be a general feature of transcription
factors that function as components of nuclear signal trans-
duction processes.
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